Journal
KIDNEY INTERNATIONAL
Volume 89, Issue 2, Pages 261-263Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.kint.2015.12.024
Keywords
-
Categories
Funding
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Neurological Diseases and Stroke
- National Institute on Aging
Ask authors/readers for more resources
The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated a significant reduction in major cardiovascular events and all-cause mortality with intensive blood pressure control in older individuals at high cardiovascular risk, including patients with chronic kidney disease and mild proteinuria. Nephrologists should consider the SPRINT results when determining the optimal blood pressure target for patients with chronic kidney disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
